Table 4.
ToxIC 2016 case demographics—HIV-positive patients
| N (%) | |
|---|---|
| Reason for encounter | |
| Intentional pharmaceutical | 42 (49.0) |
| Attempt at self-harm | 27 (31.4) |
| Misuse/abuse | 8 (9.3) |
| Therapeutic use | 3 (3.5) |
| Unknown | 4 (4.7) |
| Intentional non-pharmaceutical | 24 (28.0) |
| Attempt at self-harm | 1 (1.1) |
| Misuse/abuse | 19 (22.1) |
| Unknown | 3 (3.5) |
| Use for therapeutic intent | 1 (1.1) |
| Unintentional pharmaceutical | 1 (1.1) |
| Unintentional non-pharmaceutical | 4 (5.0) |
| Race | |
| American Indian/Alaskan Native | 1 (1.1) |
| Black/African | 29 (33.7) |
| Caucasian | 36 (42.0) |
| Other | 9 (10.5) |
| Unknown/uncertain | 11 (12.8) |
| Ethnicity | |
| Hispanic | 10 (11.6) |
| Not Hispanic | 62 (72.1) |
| Unknown | 14 (16.3) |
| Total HIV-positive patients | 86 (100) |